Vidac Pharma Holding PLC - Registered Shares

0
STU:T9G (UK)   Registered Shares
€ 0.72 (-7.69%) Oct 23
At Loss
Market Cap:
€ 39.12M ($ 42.23M)
Enterprise V:
€ 39.37M ($ 42.51M)
Volume:
303.55K
Avg Vol (2M):
824.40K
Trade In:
Volume:
303.55K
At Loss

Business Description

Vidac Pharma Holding PLC

ISIN : GB00BM9XQ619

Share Class Description:

STU:T9G: Registered Shares
Compare
Compare
Traded in other countries / regions
T9G.Germany
IPO Date
2023-08-07
Description
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its drug, VDA-1102, is at the clinical development stage as an ointment for patients with actinic keratosis, an early form of skin cancer, and in a separate trial for an indication of cutaneous T-cell lymphoma (CTCL). A second molecule, VDA-1275, with possible application for a wide range of solid tumors.
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 20.32

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History
EV-to-Forward-EBIT -19.34
EV-to-Forward-EBITDA -19.34

Financials

STU:T9G's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vidac Pharma Holding PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.027
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR (€) 0
20-Day SMA (€) 0
12-1 Month Momentum % 0
52-Week Range (€) 0.64 - 1.3
Shares Outstanding (Mil) 54.33

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vidac Pharma Holding PLC Filings

Filing Date Document Date Form
No Filing Data

Vidac Pharma Holding PLC Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Vidac Pharma Holding PLC Frequently Asked Questions

What is Vidac Pharma Holding PLC(STU:T9G)'s stock price today?
The current price of STU:T9G is €0.72. The 52 week high of STU:T9G is €1.30 and 52 week low is €0.64.
When is next earnings date of Vidac Pharma Holding PLC(STU:T9G)?
The next earnings date of Vidac Pharma Holding PLC(STU:T9G) is .
Does Vidac Pharma Holding PLC(STU:T9G) pay dividends? If so, how much?
Vidac Pharma Holding PLC(STU:T9G) does not pay dividend.

Press Release

Subject Date
No Press Release